Pre‐existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first‐line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus‐infected patients
Author:
Affiliation:
1. Gamaleya Centre for epidemiology and microbiology Moscow Russia
2. University of Siena Siena Italy
3. I‐PRO Rome Italy
4. EuResist Network Rome Italy
5. Karolinska Institutet Stockholm Sweden
Publisher
Wiley
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.5373
Reference30 articles.
1. Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project
2. EACS European AIDS Clinical Society Guidelines Version 10.0 November 2019. Accessed April 05 2021.https://www.eacsociety.org/files/2019_guidelines‐10.0_final.pdf
3. A Multiple Dose Phase 1 Assessment of Rilpivirine Long Acting in a Model of Preexposure Prophylaxis Against HIV
4. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
5. Standford University HIV drug resistance database. NNRTI resistance notes. Accessed April 05 2021.https://hivdb.stanford.edu/dr‐summary/resistance‐notes/NNRTI/#63Haddad2011
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of first-line ART regimens based on tenofovir in HIV-infected patients with pre-existing A62V mutation in reverse transcriptase;Problems of Virology;2024-07-05
2. Notable transmitted HIV drug resistance among people who inject drugs in Pakistan;2024-05-02
3. The molecular epidemiology of HIV-1 in Sweden 1996 to 2022, and the influence of migration from Ukraine;EUROSURVEILLANCE;2023
4. The molecular epidemiology of HIV-1 in Sweden 1996 to 2022, and the influence of migration from Ukraine;Eurosurveillance;2023-11-30
5. The role of HIV-1 polymorphism in the pathogenesis of the disease;HIV Infection and Immunosuppressive Disorders;2023-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3